- Home
- /
- Treatment
- /
- Page 53
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
(6aR, 10aR)-3-(1⿿,1⿿-dimethylheptyl)-ο8-tetrahydro-cannabinol-9-carboxylic acid | Systemic scleroderma | Corbus Pharmaceuticals, Inc.;100 River Ridge Drive, Suite 103;Norwood, Massachusetts, 02062 | June 10, 2015 | |
(6aR, 10aR)-3-(1,1-dimethylheptyl)-ο8-tetrahydro-cannabinol-9-carboxylic acid | Systemic scleroderma | Corbus Pharmaceuticals, Inc.;100 River Ridge Drive, Suite 103;Norwood, Massachusetts, 02062 | June 10, 2015 | |
Staphylococcal aureus protein A | Immune thrombocytopenic purpura | Protalex, Inc.;131 Columbia Turnpike, Suite 1;Florham Park, New Jersey, 07932 | June 10, 2015 | |
Recombinant human CD24FcIg (humanized fusion protein consisting of the extracellular domain of CD24 linked to IgG1 Fc domain | Graft Versus Host Disease | OncoImmune, Inc.;502 E Street, NE;Washington, District of Columbia, 20002 | June 9, 2015 | |
Fully human IgG2 monoclonal antibody that binds insulin receptors | Congenital hyperinsulinism | XOMA (US) LLC;2910 Seventh St.;Berkeley, California, 94710 | June 9, 2015 | |
Tumor-inflitrating lymphocytes; LN-144 | Malignant melanoma Stages IIb to IV | Iovance Biotherapeutics, Inc.;999 Skyway Road, Suite 150;San Carlos, California, 94070 | June 9, 2015 | |
Ivosidenib | Acute myeloid leukemia | Agios Pharmaceuticals, Inc.;88 Sidney Street;Cambridge, Massachusetts, 02139 | June 9, 2015 | |
Isocitrate dehydrogenase 1 (IDH1)-mutant inhibitor | Acute myeloid leukemia | Agios Pharmaceuticals, Inc.;88 Sidney Street;Cambridge, Massachusetts, 02139 | June 9, 2015 | |
Double stranded oligomer AD00370 RNA interference-based liver targeted therapeutic | Alpha-1 antitrypsin deficiency | Arrowhead Research Corporation;225 South Lake Avenue, Suite 1050;Pasadena, California, 91101 | June 9, 2015 | |
Adenoviral vector expressing the E.coli purine nucleoside phosphorylase gene and fludarabine | Intratumoral treatment of anatomically accessible oral and pharyngeal cancers (lip, tongue, gum, floor of mouth, salivary gland, and other oral cavity) | PNP Therapeutics, Inc.;15 Richard Arrington Jr. Blvd North;Birmingham, Alabama, 35203 | June 8, 2015 | |
Regorafenib | Hepatocellular Carcinoma | Bayer HealthCare Pharmaceuticals, Inc.;100 Bayer Blvd, P. O. Box 915;Whippany, New Jersey, 07981 | June 4, 2015 | |
Ibudilast | Krabbe disease | MediciNova, Inc.;4275 Executive Square, Suite 650;La Jolla, California, 92037 | June 1, 2015 | |
Adult hemogenic endothelial cells | Aplastic anemia aplastic anemia | HemoGenyx LLC;640 Elliott Street, Suite 108;Buffalo, New York, 14203 | May 27, 2015 | |
Prasugrel hydrochloride | Sickle cell anemia | Eli Lilly;Lilly Corporate Center;Indianapolis, Indiana, 46285 | May 26, 2015 | |
Lutetium (177Lu)-edotreotide | Gastro-entero-pancreatic neuroendocrine tumors | ITM Solucin GmbH;Lichtenbergstrasse 1, 85748 Garching; | May 21, 2015 | |
Fusion proteins composed by a genetically modified cholera toxin subunit A1, peptides from the acetylcholine receptor alpha chain and a dimer of the D fragment fromStaphylococcus aureusprotein A | Myasthenia gravis Myasthenia gravis | Toleranzia AB | May 21, 2015 | |
Reduced oxydised N-acetyl heparin | Multiple myeloma | Leadiant Biosciences Ltd | May 21, 2015 | |
AASSGVSTPGSAGHDIITEQPRS | Huntington disease | Centre National de la Recherche Scientifique (CNRS) | May 21, 2015 | |
Trehalose | Oculopharyngeal muscular dystrophy | Dr Ulrich Granzer | May 21, 2015 | |
5,7-dichloro-2-dimethylaminomethyl-8-hydroxyquinoline hydrochloride | Huntington disease | Prana Biotechnology UK Limited | May 21, 2015 | |
Humanised anti-CD37 monoclonal antibody conjugated to maytansinoid DM1 | Diffuse Large B-cell Lymphoma | Voisin Consulting S.A.R.L. | May 21, 2015 | |
2-(7-ethoxy-4-(3-fluorophenyl)-1-oxophthalazin-2(1H)-yl)-N-methyl-N-(2-methylbenzo[d]oxazol-6-yl)acetamide | Cystic fibrosis | Clinical Network Services (UK) Ltd | May 21, 2015 | |
Echinomycin | Acute myeloid leukemia | OncoImmune, Inc.;502 E. Street, NE;Washington, District of Columbia, 20002 | May 21, 2015 | |
Triheptanoin | Glucose transporter type-1 deficiency syndrome | Ultragenyx UK Limited | May 21, 2015 | |
Adult human bone-marrow-derived, ex-vivo-expanded, pooled allogeneic mesenchymal stromal cells | Buerger’s disease | Regulatory Resources Group Ltd | May 21, 2015 |